InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-32.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Stansky Michael P, 董事. Officer active across 1 company, notably TriSalus Life Sciences, Inc.. In total, 2 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €845k. Activity tracked since 23 February 2026. The latest transaction was disclosed on 14 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Stansky Michael P
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
23,501 股0Common StockSEC:0001628280-26-035662:0
243,900 股@ US$4.10100.0% 占其流量Common StockSEC:0001628280-26-010602:0
标准退出：2026年5月24日 (T+90)
2 条申报中的 2 条
About Stansky Michael P
Stansky Michael P is a Board Member at TriSalus Life Sciences, Inc. He contributes to the governance of the company by participating in strategic decisions and overseeing activities. His experience in the industry is an asset for the company's development.
